In this regard, Dinh et al. [39] presented GDF-15 a novel biomarker of deteriorating LV diastolic functions, regardless of the presence of well-established risk factors related with Left ventricle (LV) diastolic dysfunction such as coronary arterial disease and HT. Here, GDF15 is linked to hematocrit.